Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smith & Nephew

This article was originally published in The Gray Sheet

Executive Summary

Firm's recently divested bracing and support systems division, including DonJoy and ProCare orthopedics product lines, changes its name to dj Orthopedics, LLC. Sold April 30 to Chase Capital Partners, Fairfield Chase Medical Partners and senior management for approximately $202 mil., the business will focus on expanding product lines and identifying growth opportunities, including collaborations with other firms (1"The Gray Sheet" May 10, p. 23)

You may also be interested in...



Exogen Acquisition Gives Smith & Nephew Ultrasound Fracture Product

Smith & Nephew will add a non-invasive ultrasound fracture healing system to its orthopedic product line through the purchase of Piscataway, New Jersey-based Exogen. A definitive agreement for the $68 mil. cash deal was announced July 26.

Exogen Acquisition Gives Smith & Nephew Ultrasound Fracture Product

Smith & Nephew will add a non-invasive ultrasound fracture healing system to its orthopedic product line through the purchase of Piscataway, New Jersey-based Exogen. A definitive agreement for the $68 mil. cash deal was announced July 26.

Smith & Nephew To Divest DonJoy Bracing And Support Division For $200 Mil.

Smith & Nephew's bracing and support division expects to have greater control over its international distribution system once the unit is divested from the parent company.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel